References
- Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukkocidin and highly lethal necrotaising pneumonia in young immunocompetent patients // Lancet, 2002; 359: 753-759
- Grundmann H, Aanensen DM, van den Wijngaard CC, Webster C, Tami A, Feil EJ, et al. // PLoS Med, 2010; 12: 7(1)
- Holmes A, Ganner S, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin gene in England and Wales: frequency, characterization, and association with clinical disease // J Clin Microbiol, 2005; 5: 2384.-2390
- Hussain A, Robinson G, Malkin J, Duthie M, Kearns A, Perera N. Purpura fulminans in a child secondary to Panton-Valentine leukocidin-producing Staphylococcus aureus // J Med Microbiol, 2007; 56: 1407-1409
- Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus // Clin Infec Dis, 2005; 40: 941-947
- Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvment of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia // Clin Infec Dis, 1999; 29:1128-1132
- Mongodin E, Bajorel O, Hinnarsky J, Puchelle E, de Bentzmann S. Cell wall-associated protein A as a tool for immunocolonization of Staphylococcus aureus in infected airway epitelium // J Histochem Cytochem, 2000; 48: 523-534
- Morgan M. Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia // BMJ, 2005; 331: 793-794
- Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase // Pediatr Infect Dis J, 2004; 23: 87-97
- Prevost G, Mourey L, Colin DA, Menestrina G. Staphylococcal pore-forming toxins // Microbiol Immunol, 2001; 257: 58-83
- Roberts JC, Gulino SP, Peak KK, Luna VA, Sanderson R. Fatal necrotizing pneumonia due to a Panton-Valentine leukocidin positive community-associated methicillin-sensitive Staphylococcus aureus and Influenza co- infection: a case report // Ann of Clin Microbiol Antimocrob, 2008; 7: 5
- Sectish TC, Prober CG. Chapter 397-Pneumonia // In Kliegman RM, Behrman RE, Jenson HB, Stanton BF. Nelson Textbook of Pediatrics. 18th ed. Philadelphia: Saunders Elsevier; 2007; 1795-1799
- Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallance RJ, Bryant AE. Impact of Antibiotics on Expresion of Virulence-Associated Exotoxin Genes in Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus // J Infec Dis, 2007; 195: 202-211
- Who is more at risk of severe illness? What about other risks? [WHO web site] 24 February 2010. Available at: http://www.who.int/csr/disease/swineflu/frequently_asked_questions/risk/en/index.html
- Results of laboratory confirmed cases of novel influenza A H1N1. [Infectology Center of Latvia web site] Available at: http://www.lic.gov.lv/docs/268/2010/jauna%20gripa_LIC_16012010.pdf
- High pandemic (H1N1) 2009 activity, particularly in children. WHO/Europe outbreak update, 30 November 2009. Available at: http://www.euro.who.int/influenza/AH1N1/20091202_1
- Surveillance for Pediatric Deaths Associated with 2009 Pandemic Influenza A (H1N1) Virus Infection-United States, April-August 2009, September 4, 2009 / Vol. 58 / No. 34 / Pg. 941-968 Morbidity and mortality weekly report, CDC
- WHO Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and other Influenza Viruses [WHO web site]. February 2010. Available at: http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivirals_20090820/en/index.html
- Health Protection Agency. Revised guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in the UK. [HPA web site] 2008 Available at: http://www.hpa.org.uk/PVL-SA_FinalGuidance.pdf